Clinical Trial Update: Vorinostat Plus Hydroxychloroquine Versus Regorafenib in Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial comparing vorinostat plus hydroxychloroquine versus regorafenib in colorectal cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Hydroxychloroquine (hydroxychloroquine)
• Regorafenib (regorafenib)
• Vorinostat (vorinostat)

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2024-01-05